Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,361
Recruiting: 790
Ph III recruiting: 74
Growth YoY: +9.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (646)

clinicaltrialsPublishedShowing 501–550 of 1,732 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07019844	PSMA PET for the Staging and Management of Hepatocellular Carcinoma	recruiting	—	90	VA Office of Research and DevelopmentFED	1	Jun 26, 2026	clinicaltrials
NCT07110233	Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma	not yet recruiting	N/A	64	University of California, San FranciscoOTHER	1	Jun 26, 2026	clinicaltrials